Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features

G Iacobellis, AC Bianco - Trends in Endocrinology & Metabolism, 2011 - cell.com
Epicardial adipose tissue is an unusual visceral fat depot with anatomical and functional
contiguity to the myocardium and coronary arteries. Under physiological conditions …

Echocardiographic epicardial fat: a review of research and clinical applications

G Iacobellis, HJ Willens - Journal of the American Society of …, 2009 - Elsevier
Epicardial fat plays a role in cardiovascular diseases. Because of its anatomic and functional
proximity to the myocardium and its intense metabolic activity, some interactions between …

Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis

N Alexopoulos, D Katritsis, P Raggi - Atherosclerosis, 2014 - Elsevier
The current epidemic of obesity with the associated increasing incidence of insulin
resistance, diabetes mellitus and atherosclerosis affecting a large proportion of the North …

Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review

YH Chang, DM Chang, KC Lin… - … research and reviews, 2011 - Wiley Online Library
There are controversies regarding the association of visfatin with overweight/obesity, type 2
diabetes mellitus, insulin resistance (IR), metabolic syndrome and cardiovascular disease in …

Nampt: linking NAD biology, metabolism and cancer

A Garten, S Petzold, A Körner, S Imai… - Trends in endocrinology & …, 2009 - cell.com
Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to nicotinamide
mononucleotide (NMN), a key nicotinamide adenine dinucleotide (NAD) intermediate …

The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis

SW Rabkin - Metabolic syndrome and related disorders, 2014 - liebertpub.com
Epicardial fat (epicardial adipose tissue, EAT) has been implicated in the pathogenesis of
coronary artery disease (CAD). The objective of this study was to examine the relationship …

Visfatin/Nampt: an adipokine with cardiovascular impact

T Romacho, CF Sánchez-Ferrer… - Mediators of …, 2013 - Wiley Online Library
Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors
termed adipokines. Visfatin was initially identified as a novel adipokine with insulin‐mimetic …

The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease

DM Ouwens, H Sell, S Greulich… - Journal of cellular and …, 2010 - Wiley Online Library
Introduction• Fat depots around the heart and vasculature‐Definitions‐Epicardial adipose
tissue‐Perivascular adipose tissue‐Pericardial adipose tissue• Physiological function of …

Epicardial adipose tissue: a novel potential imaging marker of comorbidities caused by chronic inflammation

MG Tarsitano, C Pandozzi, G Muscogiuri, S Sironi… - Nutrients, 2022 - mdpi.com
The observation of correlations between obesity and chronic metabolic and cardiovascular
diseases has led to the emergence of strong interests in “adipocyte biology”, in particular in …

[HTML][HTML] Visfatin as a promising marker of cardiometabolic risk

M Erten - Acta Cardiologica Sinica, 2021 - ncbi.nlm.nih.gov
Adipose tissue is an endocrine organ that produces molecules with important functions in
the human body called adipokines. Visfatin can be secreted from various sources, such as …